グレヌロマによる小児クローン病の表型と臨床経過:遡及的なコホート研究
Bilge S Akkelle1, Pinar Ay2, Cigdem Celikel3
1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Marmara University School of Medicine, Istanbul, Turkey.
まとめ
小児性クローン病 (CD) の小胞腫は,より広範な疾患表型を示し,より早期の悪化や,周病のフィスティル化のリスクの増加を含む,より積極的な臨床経過に関連しています.
科学分野:
- 小児胃腸内科 小児胃腸内科
- 胃腸病理学 胃腸病理学
- 炎症性腸疾患の研究について
背景:
- 小児発症のクローン病 (Crohn's disease,CD) での花粉腫の臨床的意義は不明である.
- グラヌロマの役割を理解することは,疾患の進行を予測し,若いCD患者の治療を最適化するために不可欠です.
研究 の 目的:
- 顆粒腫と小児CDのフェノタイプとの関連を調査する.
- 小児CD患者の臨床経過と長期的なアウトカムを分析する.
主な方法:
- 81人の小児CD患者の317回の内視鏡検査で得られた組織病理学的発見の遡及的分析.
- バイオプシーで検出された花粉腫と無花粉腫の患者の疾患フェノタイプと臨床フォローアップデータの比較.
主要な成果:
- 小粒腫は,小児CD患者の39.5%に診断時に存在していました.
- グランウロマの存在は,イレオコロニック疾患,上部GI関わり,中等重度の疾患活動と相関する.
- 顆粒腫は,早期の悪化と,フィスティュライズ perianal 疾患のより高い発生率と関連していました.
結論:
- 小児CDの粒腫は,独特で広範囲な疾患現象型と関連しています.
- 顆粒腫は,小児CDにおける攻撃的な疾患進行の予測要因として機能する.
- 顆粒腫の存在は,小児クローン病の治療戦略に影響を与える可能性があります.
関連する概念動画
01:17Chronic Bowel Disorders: Introduction
908
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
908
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
780
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
780
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
703
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
703
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.6K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
01:25Inflammatory Bowel Disease III: Crohn's Disease
75
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
75
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
64
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64